NasdaqGS:CRVL

Stock Analysis Report

Executive Summary

CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has CorVel's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.6%

CRVL

3.9%

US Healthcare

0.07%

US Market


1 Year Return

42.4%

CRVL

-6.7%

US Healthcare

8.9%

US Market

Return vs Industry: CRVL exceeded the US Healthcare industry which returned -6.7% over the past year.

Return vs Market: CRVL exceeded the US Market which returned 8.9% over the past year.


Shareholder returns

CRVLIndustryMarket
7 Day-1.6%3.9%0.07%
30 Day-7.2%3.5%-0.3%
90 Day-17.0%-0.05%-1.6%
1 Year42.4%42.4%-5.1%-6.7%11.3%8.9%
3 Year124.7%124.7%37.0%30.6%46.3%36.8%
5 Year133.0%133.0%61.3%50.4%62.1%44.3%

Price Volatility Vs. Market

How volatile is CorVel's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CorVel undervalued compared to its fair value and its price relative to the market?

6.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CRVL ($77.2) is trading below our estimate of fair value ($82.84)

Significantly Below Fair Value: CRVL is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: CRVL is poor value based on its PE Ratio (29.9x) compared to the Healthcare industry average (21x).

PE vs Market: CRVL is poor value based on its PE Ratio (29.9x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CRVL is overvalued based on its PB Ratio (7x) compared to the US Healthcare industry average (2.5x).


Next Steps

Future Growth

How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

3.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRVL's forecast earnings growth (3.2% per year) is above the savings rate (2.7%).

Earnings vs Market: CRVL's earnings (3.2% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: CRVL's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if CRVL's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if CRVL's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CRVL's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has CorVel performed over the past 5 years?

9.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CRVL's earnings have grown by 9.6% per year over the past 5 years.

Accelerating Growth: CRVL's earnings growth over the past year (24.9%) exceeds its 5-year average (9.6% per year).

Earnings vs Industry: CRVL earnings growth over the past year (24.9%) exceeded the Healthcare industry 5.6%.


Return on Equity

High ROE: CRVL's Return on Equity (23.7%) is considered high.


Return on Assets

ROA vs Industry: CRVL has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: CRVL's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is CorVel's financial position?


Financial Position Analysis

Short Term Liabilities: CRVL's short term assets ($221.6M) exceeds its short term liabilities ($130.7M)

Long Term Liabilities: CRVL's short term assets (221.6M) exceeds its long term liabilities (93.3M)


Debt to Equity History and Analysis

Debt Level: CRVL is debt free.

Reducing Debt: CRVL has not had any debt for past 5 years.

Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: CRVL has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if CRVL's debt is covered by short term assets.


Next Steps

Dividend

What is CorVel's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CRVL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of CorVel's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average management tenure


CEO

Michael Combs (55yo)

0.8yrs

Tenure

US$1,770,006

Compensation

Mr. Michael G. Combs has been as the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp  ...


CEO Compensation Analysis

Compensation vs. Market: Michael has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.

Compensation vs Earnings: Michael's compensation has increased by more than 20% in the past year.


Management Age and Tenure

2.9yrs

Average Tenure

51.5yo

Average Age

Experienced Management: CRVL's management team is considered experienced (2.9 years average tenure).


Board Age and Tenure

28.4yrs

Average Tenure

71yo

Average Age

Experienced Board: CRVL's board of directors are seasoned and experienced ( 28.4 years average tenure).


Insider Trading

Insider Buying: CRVL insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$168,31711 Sep 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares2,000
Max PriceUS$86.13
SellUS$85,62706 Sep 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares1,000
Max PriceUS$85.63
SellUS$250,70529 Aug 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares3,000
Max PriceUS$85.29
SellUS$10,06223 Aug 19
Alan Hoops
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares117
Max PriceUS$86.00
SellUS$316,20223 Aug 19
Alan Hoops
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,673
Max PriceUS$86.09
SellUS$85,44623 Aug 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares1,000
Max PriceUS$85.45
SellUS$343,10320 Aug 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares4,000
Max PriceUS$86.03
SellUS$435,66020 Aug 19
Alan Hoops
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares5,046
Max PriceUS$86.50
SellUS$261,22915 Aug 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares3,000
Max PriceUS$88.15
SellUS$81,75017 Jun 19
Diane Blaha
EntityIndividual
Role
Head of Marketing
Chief Marketing Officer
Shares1,000
Max PriceUS$81.75
SellUS$458,67114 Jun 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares5,566
Max PriceUS$82.94
SellUS$75,52506 Jun 19
Brandon O’Brien
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares1,015
Max PriceUS$74.41
SellUS$99,90006 Jun 19
Michael Combs
EntityIndividual
Role
Chief Executive Officer
President & CEO
Shares1,350
Max PriceUS$74.00
SellUS$359,67506 Jun 19
R. Jessup
EntityIndividual
Role
Lead Director
Lead Independent Director
Shares4,859
Max PriceUS$74.02
SellUS$222,78706 Jun 19
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares3,000
Max PriceUS$74.83
SellUS$66,34530 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares1,000
Max PriceUS$66.35
SellUS$197,67429 Nov 18
R. Jessup
EntityIndividual
Role
Lead Director
Lead Independent Director
Shares3,000
Max PriceUS$66.14
SellUS$111,58327 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares1,700
Max PriceUS$65.83
SellUS$143,44121 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares2,200
Max PriceUS$65.24
SellUS$305,72019 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares4,700
Max PriceUS$65.48
SellUS$46,57714 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares722
Max PriceUS$64.52
SellUS$169,42009 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares2,600
Max PriceUS$65.40
SellUS$187,02206 Nov 18
Victor Clemons
EntityIndividual
Role
Chairman of the Board
Chairman & COO
Shares3,000
Max PriceUS$63.81

Ownership Breakdown


Management Team

  • Richard Schweppe (64yo)

    Secretary

    • Tenure: 24.3yrs
    • Compensation: US$223.00k
  • Victor Clemons (75yo)

    Chairman & COO

    • Tenure: 28.5yrs
    • Compensation: US$401.01k
  • Diane Blaha (64yo)

    Chief Marketing Officer

    • Tenure: 2.9yrs
    • Compensation: US$703.75k
  • Sharon O'Connor

    Vice President of Legal & Human Resources

    • Tenure: 3.5yrs
  • Michael Combs (55yo)

    President & CEO

    • Tenure: 0.8yrs
    • Compensation: US$1.77m
  • Michael Saverien (48yo)

    Executive Vice President of Risk Management Services

    • Tenure: 2.5yrs
    • Compensation: US$669.24k
  • Maxim Shishin (44yo)

    Chief Information Officer

    • Tenure: 2.5yrs
    • Compensation: US$523.51k
  • Stefani Wendel

    Investor Relation

    • Tenure: 0yrs
  • Jennifer Yoss (41yo)

    Vice President of Accounting

    • Tenure: 5.3yrs
    • Compensation: US$251.78k
  • Brandon O’Brien (39yo)

    Chief Financial Officer

    • Tenure: 1yrs
    • Compensation: US$498.54k

Board Members

  • Steve Hamerslag (62yo)

    Independent Director

    • Tenure: 28.4yrs
    • Compensation: US$81.24k
  • Victor Clemons (75yo)

    Chairman & COO

    • Tenure: 28.5yrs
    • Compensation: US$401.01k
  • Jeff Michael (62yo)

    Independent Director

    • Tenure: 29.1yrs
    • Compensation: US$77.24k
  • R. Jessup (71yo)

    Lead Independent Director

    • Tenure: 0yrs
    • Compensation: US$87.24k
  • Alan Hoops (71yo)

    Independent Director

    • Tenure: 16.4yrs
    • Compensation: US$80.24k
  • Jean Macino (76yo)

    Independent Director

    • Tenure: 11.7yrs
    • Compensation: US$78.42k

Company Information

CorVel Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CorVel Corporation
  • Ticker: CRVL
  • Exchange: NasdaqGS
  • Founded: 1987
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$1.426b
  • Shares outstanding: 18.47m
  • Website: https://www.corvel.com

Number of Employees


Location

  • CorVel Corporation
  • 2010 Main Street
  • Suite 600
  • Irvine
  • California
  • 92614
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRVLNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJun 1991

Biography

CorVel Corporation provides workers’ compensation solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. I ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 23:34
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.